These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10759883)

  • 1. Intrapleural administration of tumour necrosis factor-alpha (TNFalpha) in patients with mesothelioma: cytokine patterns and acute-phase protein response.
    Stam TC; Swaak AJ; Kruit WH; Stoter G; Eggermont AM
    Eur J Clin Invest; 2000 Apr; 30(4):336-43. PubMed ID: 10759883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma.
    Nakano T; Chahinian AP; Shinjo M; Tonomura A; Miyake M; Togawa N; Ninomiya K; Higashino K
    Br J Cancer; 1998 Mar; 77(6):907-12. PubMed ID: 9528833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic toxicity and cytokine/acute phase protein levels in patients after isolated limb perfusion with tumor necrosis factor-alpha complicated by high leakage.
    Stam TC; Swaak AJ; de Vries MR; ten Hagen TL; Eggermont AM
    Ann Surg Oncol; 2000 May; 7(4):268-75. PubMed ID: 10819366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of iron metabolism in the acute-phase response: interferon gamma and tumour necrosis factor alpha induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients.
    Feelders RA; Vreugdenhil G; Eggermont AM; Kuiper-Kramer PA; van Eijk HG; Swaak AJ
    Eur J Clin Invest; 1998 Jul; 28(7):520-7. PubMed ID: 9726030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study.
    Goey SH; Eggermont AM; Punt CJ; Slingerland R; Gratama JW; Oosterom R; Oskam R; Bolhuis RL; Stoter G
    Br J Cancer; 1995 Nov; 72(5):1283-8. PubMed ID: 7577483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of anaesthesia based on high versus low doses of opioids on the cytokine and acute-phase protein responses in patients undergoing cardiac surgery.
    Brix-Christensen V; Tønnesen E; Sørensen IJ; Bilfinger TV; Sanchez RG; Stefano GB
    Acta Anaesthesiol Scand; 1998 Jan; 42(1):63-70. PubMed ID: 9527747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiles of cytokines (TNF alpha and IL-6) and acute phase proteins (CRP and alpha 1AG) related to the disease course in patients with systemic lupus erythematosus.
    Meijer C; Huysen V; Smeenk RT; Swaak AJ
    Lupus; 1993 Dec; 2(6):359-65. PubMed ID: 7511020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients.
    Castagneto B; Zai S; Mutti L; Lazzaro A; Ridolfi R; Piccolini E; Ardizzoni A; Fumagalli L; Valsuani G; Botta M
    Lung Cancer; 2001; 31(2-3):303-10. PubMed ID: 11165411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma: a Phase II study.
    Astoul P; Picat-Joossen D; Viallat JR; Boutin C
    Cancer; 1998 Nov; 83(10):2099-104. PubMed ID: 9827714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease.
    Fiotti N; Giansante C; Ponte E; Delbello C; Calabrese S; Zacchi T; Dobrina A; Guarnieri G
    Atherosclerosis; 1999 Jul; 145(1):51-60. PubMed ID: 10428295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
    Rusch VW; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M
    J Clin Oncol; 1992 Jun; 10(6):1001-6. PubMed ID: 1588364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of recombinant tumour necrosis factor (rTNF-alpha) in cancer. Observations on the acute phase protein reaction and immunoglobulin synthesis after high dose recombinant TNF-alpha administration in isolated limb perfusions in cancer patients.
    Swaak AJ; Lienard D; Schraffordt Koops H; Lejeune FJ; Eggermont AM
    Eur J Clin Invest; 1993 Dec; 23(12):812-8. PubMed ID: 7511535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute-phase response patterns in isolated hepatic perfusion with tumour necrosis factor alpha (TNF-alpha) and melphalan in patients with colorectal liver metastases.
    De Vries MR; Borel Rinkes IH; Swaak AJ; Hack CE; Van De Velde CJ; Wiggers T; Tollenaar RA; Kuppen PJ; Eggermont AM
    Eur J Clin Invest; 1999 Jun; 29(6):553-60. PubMed ID: 10354218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label phase I pilot study of continuous intrapleural infusion of escalated doses of methotrexate in malignant pleural mesothelioma.
    Ellithy MM; El Baghdady NS; El Wakeel LM; Abdeltawab KA; Badary OA
    Am J Clin Oncol; 2013 Oct; 36(5):514-8. PubMed ID: 22781392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmented enhancement of in vitro production of inflammatory cytokines in peripheral blood mononuclear cells in patients undergoing simultaneous resection of the liver and gastrointestinal tract.
    Sasada K; Miyazaki M; Nakagawa K; Ito H; Ambiru S; Shimizu H; Nakajima N
    Crit Care Med; 1999 May; 27(5):929-36. PubMed ID: 10362415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.
    Schols AM; Buurman WA; Staal van den Brekel AJ; Dentener MA; Wouters EF
    Thorax; 1996 Aug; 51(8):819-24. PubMed ID: 8795671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapleural production of interleukin 6 during mesothelioma and its modulation by gamma-interferon treatment.
    Monti G; Jaurand MC; Monnet I; Chretien P; Saint-Etienne L; Zeng L; Portier A; Devillier P; Galanaud P; Bignon J
    Cancer Res; 1994 Aug; 54(16):4419-23. PubMed ID: 8044791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced hyperergic vasculitis--activity of selected cytokines and acute phase proteins in plasma.
    Chodorowska G; Czelej D
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):43-7. PubMed ID: 15314957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma: a Phase II study.
    Karrison TG; Vogelzang NJ
    Cancer; 1999 Aug; 86(3):546-7. PubMed ID: 10430267
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-induced urticaria--activity of selected cytokines and acute phase proteins in plasma.
    Czelej D; Chodorowska G; Lechowska-Mazur I
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):38-42. PubMed ID: 15314956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.